[Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein]. / Lutetium-177-PSMA-Radioligandentherapie : Konsensus im Rahmen der GKV-finanzierten Versorgung zwischen den Hochschulkliniken in Aachen, Bonn, Düsseldorf, Essen und Köln und dem MDK Nordrhein.
Urologe A
; 57(6): 709-713, 2018 Jun.
Article
in De
| MEDLINE
| ID: mdl-29671080
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Radioisotopes
/
Health Care Costs
/
Prostatic Neoplasms, Castration-Resistant
/
Insurance, Health
/
Insurance, Health, Reimbursement
/
Lutetium
Type of study:
Clinical_trials
/
Guideline
Limits:
Humans
/
Male
Country/Region as subject:
Europa
Language:
De
Journal:
Urologe A
Year:
2018
Document type:
Article
Country of publication: